212 related articles for article (PubMed ID: 14652713)
21. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
[TBL] [Abstract][Full Text] [Related]
22. An improved 32P-postlabeling/high-performance liquid chromatography method for the analysis of the malondialdehye-derived 1, N2-propanodeoxyguanosine DNA adduct in animal and human tissues.
Yi P; Sun X; Doerge DR; Fu PP
Chem Res Toxicol; 1998 Sep; 11(9):1032-41. PubMed ID: 9760277
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen-DNA adducts detected in the endometrium of women treated with tamoxifen.
Shibutani S; Suzuki N; Terashima I; Sugarman SM; Grollman AP; Pearl ML
Chem Res Toxicol; 1999 Jul; 12(7):646-53. PubMed ID: 10409405
[TBL] [Abstract][Full Text] [Related]
24. DNA adduct formation and physiological effects from crude oil distillate and its derived base oil in isolated, perfused rat liver.
Nagy E; Norén UG; Zeisig M; Ekström LG; Möller L
Arch Toxicol; 2004 Feb; 78(2):114-21. PubMed ID: 14647976
[TBL] [Abstract][Full Text] [Related]
25. 32P-HPLC suitable for characterization of DNA adducts formed in vitro by polycyclic aromatic hydrocarbons and derivatives.
Zeisig M; Möller L
Carcinogenesis; 1995 Jan; 16(1):1-9. PubMed ID: 7834791
[TBL] [Abstract][Full Text] [Related]
26. Development of a 32P-postlabeling method for the detection of 1, N2-propanodeoxyguanosine adducts of 2-hexenal in vivo.
Schuler D; Budiawan B; Eder E
Chem Res Toxicol; 1999 Apr; 12(4):335-40. PubMed ID: 10207122
[TBL] [Abstract][Full Text] [Related]
27. Detection of multiple polycyclic aromatic hydrocarbon-DNA adducts by a high-performance liquid chromatography-32P-postlabeling method.
Gorelick NJ; Reeder NL
Environ Health Perspect; 1993 Mar; 99():207-11. PubMed ID: 8319625
[TBL] [Abstract][Full Text] [Related]
28. High-resolution anion-exchange and partition thin-layer chromatography for complex mixtures of 32P-postlabeled DNA adducts.
Spencer-Beach GG; Beach AC; Gupta RC
J Chromatogr B Biomed Appl; 1996 Mar; 677(2):265-73. PubMed ID: 8704930
[TBL] [Abstract][Full Text] [Related]
29.
Phillips DH; Arlt VM
Methods Mol Biol; 2020; 2102():291-302. PubMed ID: 31989562
[No Abstract] [Full Text] [Related]
30. Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens.
Farmer PB; Singh R
Mutat Res; 2008; 659(1-2):68-76. PubMed ID: 18468947
[TBL] [Abstract][Full Text] [Related]
31. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
Dreij K; Seidel A; Jernström B
Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
[TBL] [Abstract][Full Text] [Related]
32. Detection of DNA adducts by 32P-postlabeling and multifraction contact-transfer thin-layer chromatography.
Laws GM; Adams SP; Nichols WW; Selden JR
Fundam Appl Toxicol; 1994 Aug; 23(2):308-12. PubMed ID: 7982538
[TBL] [Abstract][Full Text] [Related]
33. Application of HPLC in the 32P-postlabeling assay.
Gorelick NJ
Mutat Res; 1993 Jul; 288(1):5-18. PubMed ID: 7686266
[TBL] [Abstract][Full Text] [Related]
34. Hepatic DNA adduct dosimetry in rats fed tamoxifen: a comparison of methods.
Schild LJ; Phillips DH; Osborne MR; Hewer A; Beland FA; Churchwell MI; Brown K; Gaskell M; Wright E; Poirier MC
Mutagenesis; 2005 Mar; 20(2):115-24. PubMed ID: 15755801
[TBL] [Abstract][Full Text] [Related]
35. ³²P-postlabelling for the sensitive detection of DNA adducts.
Jones NJ
Methods Mol Biol; 2012; 817():183-206. PubMed ID: 22147574
[TBL] [Abstract][Full Text] [Related]
36. Characterization and quantitative analysis of DNA adducts formed from lower chlorinated PCB-derived quinones.
Zhao S; Narang A; Ding X; Eadon G
Chem Res Toxicol; 2004 Apr; 17(4):502-11. PubMed ID: 15089092
[TBL] [Abstract][Full Text] [Related]
37. Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen.
Shibutani S; Suzuki N; Laxmi YR; Schild LJ; Divi RL; Grollman AP; Poirier MC
Cancer Res; 2003 Aug; 63(15):4402-6. PubMed ID: 12907611
[TBL] [Abstract][Full Text] [Related]
38. Analysis of tamoxifen-induced DNA adducts by 32P-postlabelling assay using different chromatographic techniques.
Koskinen M; Rajaniemi H; Hemminki K
J Chromatogr B Biomed Sci Appl; 1997 Mar; 691(1):155-60. PubMed ID: 9140769
[TBL] [Abstract][Full Text] [Related]
39. Comparison of TLC- and HPLC-32P-postlabelling assay for cisplatin-DNA adducts.
Försti A; Staffas J; Hemminki K
Carcinogenesis; 1994 Dec; 15(12):2829-34. PubMed ID: 8001242
[TBL] [Abstract][Full Text] [Related]
40. [The formation of BPDE-DNA adduct in rat and its determination by high performance liquid chromatography].
Yang LH; Liu Q; Sun CJ; Guo SY; Lin SJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):302-4. PubMed ID: 18630709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
